Storys zum Thema Wirtschaft

Folgen
Keine Story zum Thema Wirtschaft mehr verpassen.
Filtern
  • 06.06.2006 – 12:18

    BASF SE

    BASF Receives Majority of Engelhard Shares

    Ludwigshafen, Germany (ots/PRNewswire) - - BASF-CEO Hambrecht: 'Special day for BASF and Engelhard, more innovative solutions for customers.' - Subsequent offering period to expire on June 8, 2006 BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced the expiration of its initial tender offer period to purchase all of the outstanding shares of Engelhard Corporation ...

  • 30.05.2006 – 14:41

    BASF SE

    BASF and Engelhard Reach Agreement

    Ludwigshafen, Germany (ots/PRNewswire) - - Engelhard Recommends That Engelhard's Shareholders Accept BASF's Offer - BASF CEO Hambrecht: "Crucial step towards acquisition of Engelhard." BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) announced today that it signed a definitive agreement with Engelhard Corporation (NYSE: EC). According to the agreement, Engelhard will recommend that Engelhard shareholders tender their shares to BASF ...

  • 23.05.2006 – 17:06

    Boehringer Ingelheim

    New Data Shed Light on the Global Incidence of Constipation

    Ingelheim, Germany (ots/PRNewswire) - - Not for Distribution or Publication in the United States New omnibus data from the largest global survey due to be published, conducted on the epidemiology of constipation, were presented today at the Digestive Disease Week congress in Los Angeles. The survey, sponsored by Boehringer Ingelheim, offers new insights into the incidence of constipation and shows that ...

  • 26.04.2006 – 21:22

    BASF SE

    BASF Considers All Options

    Ludwigshafen, Germany (ots/PRNewswire) - - BASF's All-Cash Bid Provides Greater Value and Certainty than Engelhard's Proposal BASF is considering all its options after Engelhard's Board of Directors rejected an increased cash offer of US$38 per share proposed by BASF, as part of a negotiated merger transaction, and elected instead to pursue a partial share buyback plan. Following a preliminary review of Engelhard's proposed transaction, BASF continues to ...

  • 21.04.2006 – 15:55

    Viscom AG

    Not only for medical purposes: Computer tomography improves industrial production

    Hanover (ots) - Hanover Fair Hall 17, Stand B76 3D inspection of electronic components - more safety, lower recall rate, less reject due to defects - Viscom anticipates a market potential worth millions. Established already in medicine, the computer tomography (CT) swiftly conquers the realm of industrial production. Some of the benefits for manufacturers and ...

  • 21.04.2006 – 15:51

    Viscom AG

    Viscom AG Strives for Initial Opening in May

    Hanover (ots) - Hanover Fair Hall 17, Stand B76 Stock exchange plans solidified - transaction volume of from 40 to 60 million euros - 80 percent of the capital to flow back into the company The Viscom AG, supplier of automatic optical inspection systems for the electronics industry, solidifies their stock exchange plans: the initial listing in the Prime Standard of the Frankfurt Stock Exchange shall take ...

  • 17.04.2006 – 13:01

    BASF SE

    BASF Extends US$37 Cash Tender Offer to April 28, 2006

    Ludwigshafen, Germany (ots/PRNewswire) - BASF Aktiengesellschaft (Frankfurt: BAS; NYSE: BF [ADR]; LSE: BFA; SWX: AN) today announced that, through its wholly owned subsidiary, Iron Acquisition Corporation, it has extended the expiration date of its US$37 cash tender offer for all of the issued and outstanding shares of common stock of Engelhard Corporation (NYSE: EC) to 5:00 p.m., New York City time, on Friday, ...

  • 24.02.2006 – 10:05

    Boehringer Ingelheim

    Boehringer Ingelheim Receives Recommendation From EU Scientific Committee for Sifrol(R)/ Mirapexin(R) (Pramipexole) for the Treatment of Restless Legs Syndrome (RLS)

    Ingelheim, Germany (ots/PRNewswire) - - For Non-US Healthcare Professional Media Boehringer Ingelheim announced today that that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of Sifrol(R) / Mirapexin(R) ...

  • 28.07.2005 – 15:53

    Boehringer Ingelheim

    Positive Opinion in Europe for Tipranavir

    Rio De Janeiro, Brazil and Ingelheim, Germany (ots/PRNewswire) - - New Data Support its Use as Powerful Treatment Against HIV Drug Resistance RIO DE JANEIRO, Brazil and INGELHEIM, Germany, July 28 /PRNewswire/ -- Boehringer Ingelheim announced today that the CHMP (Committee for Medicinal Products for Human Use) in London has issued a positive opinion for tipranavir, a non-peptidic protease inhibitor, to ...

  • 18.03.2005 – 12:00

    Sharp Electronics (Europe) GmbH

    Double the Business!

    Hamburg, Germany (ots) - - cross-reference: The detailled version of the press release is available under http://www.presseportal.de/dokumente.html - Sharp Electronics Europe CEO Hans Kleis wants to double the turnover of the Japanese technology group in Europe by the end of fiscal year 2007 by focusing on the three strategic divisions of LCD TV, Document Solutions and ...

    Ein Dokument
  • 01.11.2004 – 14:14

    Boehringer Ingelheim

    Boehringer Ingelheim Announces 24-Week Interim Results from Tipranavir RESIST-1 Phase 3 Study

    Washington, November 1 (ots/PRNewswire) - New data from a pivotal Phase 3 study (RESIST-1) demonstrate that a statistically significant greater percentage of HIV-positive patients taking a tipranavir-based regimen achieved a treatment response versus those taking a regimen containing one of several marketed protease inhibitors (PIs). Treatment response in this study ...

  • 25.10.2004 – 08:04

    Boehringer Ingelheim

    Boehringer Ingelheim Submits Marketing Authorisation Application to European Union and to the FDA for Investigational Anti-HIV Agent Tipranavir

    Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim today announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for tipranavir. Simultaneously the documentation was submitted to the FDA. Tipranavir is a non-peptidic protease inhibitor (NPPI) for ...

  • 20.07.2004 – 12:43

    Kabel Deutschland Holding AG

    Kabel Deutschland announces Insa Calsow as Director of Investor Relations and Finance

    Unterfoehring, Germany (ots) - Kabel Deutschland (KDG) today announced that Insa Calsow will join the company as Director of Investor Relations and Finance on September 1st 2004. Insa Calsow will report to KDG's Chief Financial Officer, Paul Thomason. She will be responsible for Investor Relations and for certain aspects of Corporate Finance. Mrs. Calsow comes ...

  • 24.06.2004 – 10:00

    LPKF Laser & Electronics AG

    LPKF and BASF close know-how and licence agreement

    Garbsen/Hannover/Ludwigshafen (ots) - Laser manufacturer LPKF AG and the plastic producer BASF AG signed a know-how and licence agreement covering the LDS method for the production of 3D electronic circuits (3D-MID). This agreement makes new materials (PA, POM, PES and PSU) available worldwide for the LPKF LDS method. The high performance technical plastics made by BASF AG are already used for the production of ...

  • 26.02.2004 – 14:36

    Freudenberg & Co. Kommanditgesellschaft

    Freudenberg forms new Chemical Specialities Business Group

    Weinheim/Munich (ots) - Klüber remains key company / Chem-Trend rounds off portfolio Freudenberg & Co., Weinheim, Germany, has acquired the US release agents company Chem-Trend, of Howell, Michigan. The takeover reinforces the specialities operations of the diversified industrial Group. In order to consolidate the lubrication activities Freudenberg has formed the new business group, "Freudenberg ...

  • 30.01.2004 – 06:00

    Deutsche Bundesstiftung Umwelt (DBU)

    On good terms with long lines: Oil-pipelines soon safer

    Osnabruck, Germany (ots) - Medium-sized company from Darmstadt develops new technology aimed on early detection of leaks - Tests in Russia and China - Financial backing from the DBU Are oil-pipelines ticking eco-bombs? 74 million litres of oil are supposed to having polluted the Ecuadorian Amazon area in the last 30 years - far more than the leakage on the occasion of the Exxon Valdez accident. And the ...

  • 17.12.2003 – 08:00

    Audi AG

    Audi celebrates successes in China

    Ingolstadt/Changchun/Beijing (ots) - - Cross-reference: photo will be sent via satellite and is at http://www.presseportal.de/galerie.htx?type=obs available - - Record month in November - Production running at full capacity - Now 85 exclusive dealerships - Third largest market for the Audi A8 "Audi's business in China has reached new heights," declared Erich Schmitt, Member of the Board of Management of AUDI AG and also responsible ...

  • 27.11.2003 – 12:27

    hotelleriesuisse

    hotelleriesuisse: Swiss Hotel Stars to Shine Brighter in 2006

    Olten (ots) - The delegates at the winter meeting of hotelleriesuisse have approved a motion to adapt the hotel classification system so as to better meet the needs of future hotel guests. Beginning in 2006, Swiss hotel stars are expected to shine more brightly thanks to increased proprietary protection, the introduction of the honorary designation "Superior", greater quality assurance and independent auditing. A ...